MREO vs UDR · $48.7M cap vs P/E 26, rev $1.71B
Mereo BioPharma Group PLC ADR (MREO) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
MREO currently screens at market cap $48.7M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the MREO and UDR stock pages for the full models.
Not investment advice.